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Formulation of Metformin-Loaded Alginate Microspheres by Ionotropic Gelation-
Aerosolization Technique 
(Formulasi Mikrosfera Alginat Muatan-Metformin oleh Pengegelan Ionotropik- Kaedah Aerosol)





Metformin hydrochloric acid (HCl)-loaded alginate microspheres prepared using aerosolization method were 
subsequently evaluated for their physico-chemical characteristics in terms of particle size, morphology, drug 
loading, entrapment efficiency, yield and in vitro release. A two factorial Design of Experiment (DoE) was used to 
study the influence of polymer alginate and cross-linker calcium chloride (CaCl2) concentrations on microparticle 
characteristics. The results indicated that all microspheres were spherical in shape, while their particle size was 
less than 5 µm, although this increased with the intensification of alginate and CaCl2 concentrations. Encapsulation 
efficiency, loading, and yield were all enhanced by increasing alginate concentration and, conversely, decreasing 
CaCl2 concentration. The highest encapsulation efficiency, loading, and yield were 40, 31, and 73%, respectively, 
produced by a formula containing 1.75% alginate and 3% CaCl2. The drug release of Metformin-loaded microparticles 
in HCl pH 1.2 ranged from 22 to 28% during a two-hour period, while further drug release of PBS pH 7.4 increased 
from 67 to 95% over ten hours. The total amount of drug released during a 12-h period increased by reducing alginate 
concentration. Furthermore, a kinetic study of the dissolution data confirmed the prevalence of a diffusion-controlled 
mechanism or Higuchi pattern of drug release.
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ABSTRAK
Mikrosfera alginat muatan-metformin asid hidroklorik (HCl) yang disediakan menggunakan kaedah aerosol 
telah dinilai untuk ciri fizikal-kimia berdasarkan saiz zarah, morfologi, muatan ubat, kecekapan pemerangkapan, 
kadar hasil dan pelepasan in vitro. Dua reka bentuk uji kaji (DoE) faktoran digunakan untuk mengkaji pengaruh 
alginat polimer dan kepekatan penghubung silang kalsium klorida (CaCl2) pada ciri mikrozarah. Keputusan kajian 
menunjukkan bahawa kesemua mikrosfera mempunyai bentuk sfera, manakala saiz zarah kurang daripada 5 µm, 
walaupun ia meningkat dengan pengamatan alginat dan kepekatan CaCl2. Kecekapan pengapsulan, muatan, kadar 
hasil kesemuanya dipertingkat dengan peningkatan kepekatan alginat dan sebaliknya penurunan kepekatan CaCl2. 
Kecekapan pengkapsulan, muatan dan kadar hasil tertinggi masing-masing adalah 40,31 dan 73%, dihasilkan 
dengan formula yang mengandungi alginat 1.75% dan CaCl2 3%. Perlepasan ubat mikrozarah muatan-metformin 
dalam HCl pH 1.2 berjulat antara 22 sehingga 28% ketika tempoh dua jam, manakala perlepasan ubat daripada 
PBS pH 7.4 meningkat daripada 67 sehingga 95% dalam masa 10 jam. Jumlah keseluruhan  perlepasan ubat ketika 
tempoh 12 jam meningkat dengan penurunan kepekatan alginat. Selain itu, kajian kinetik berkenaan data perlarutan 
memperakui prevalens mekanisme terkawal-penyerapan atau pola Higuchi perlepasan ubat.
Kata kunci: Aerosol; metformin; mikrosfera alginat; reka bentuk uji kaji 
INTRODUCTION
Metformin is an orally-administered anti-hyperglycemic 
drug commonly prescribed for the treatment of type 
2 diabetes mellitus (Choudhury et al. 2009). Oral 
administration of metformin HCl is characterized by 
a short half life (1.5 - 3 h) and incomplete absorption. 
Following administration, metformin is primarily 
absorbed by the small intestine and has a relatively low 
bioavailability of 50 to 60% (Venkateswara et al. 2013). 
Commercial metformin products are generally immediate 
release formulations which should be administered 
2 - 3 times daily in order to maintain optimum plasma 
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concentration. The clinical application of these products 
has been associated with a high incidence of gastrointestinal 
side effects such as nausea, difficulty swallowing, and 
abdominal cramps and diarrhea. Therefore, considerable 
interest has developed in producing sustained release 
formulations which improve the oral bioavailability of 
metaformin, reduce dosing frequency and promote greater 
patient compliance (Ghodake et al. 2010; Venkateswara 
et al. 2013).
Microparticles (1 - 1000 µm) have been widely 
employed to enhance the stability and absorption of drugs. 
The particles are often composed of biocompatible 
polymers and consist of a polymeric matrix, in which 
drug molecules are dispersed, entrapped, or adsorbed. 
Microparticles smaller than 200 µm have also demonstrated 
a more prolonged transit period and are desirable in 
promoting sustained or controlled drug release over 
longer periods of time, thereby reducing both dosage 
and potential side effects (Dashora & Jain 2009; Hasan et 
al. 2012; Rijal et al. 2010). Alginate is a natural anionic 
polymer composed of units of 1,4’-β-D-mannuronic acid 
(M) and α-L-guluronic acid (G) which possesses the 
unique capacity to form stable hydrogel microparticles 
under mild conditions through the addition of multivalent 
cations. Basically, alginate interacts with multivalent 
cations to form ionic bridges between adjacent alginate 
chains. This ionotropic gelation procedure is often 
combined with droplet generation techniques (e.g. 
emulsification and spray-drying) to produce alginate 
microparticles.
Numerous reports have shown that the nanoparticles 
significantly promote enhanced absorption of drugs 
due to their large surface area and, consequently, 
opportunities for interaction between the nano particles 
and the absorption surfaces on a larger scale (Banerjee 
et al. 2016; Jia 2005; Rizvi & Saleh 2018). However, 
other reports have indicated that if the objective is to 
extend the release of the drugs, then larger particles 
(microspheres vs nanospheres) may prove more effective. 
Reineke et al. (2013) reported that microspheres with 
particles larger than 5000 nm (5 microns) have been 
shown to have an advantage over nanoparticles below 500 
nm. For the purposes of their experiment, Reineke et al. 
(2013) used nonbiodegradable polystyrene microspheres 
(diameter range: 500 nm to 5 µm) which were delivered 
locally to the jejunum or ileum of young male rats by oral 
administration. Following administration, microspheres 
were absorbed rapidly (≤ 5 min) by the small intestine and 
subsequently detected by transmission electron microscopy 
and confocal laser scanning microscopy. Gel permeation 
chromatography confirmed that polymer was present in 
all tissue samples, including those from the brain. These 
results confirmed that microspheres (diameter range: 500 
nm to 5 µm) were absorbed by the small intestine and 
distributed throughout the body of the rat. 
In another study reported by Morishita et al. (2004), 
insulin-loaded polymer (ILP) microparticles composed 
of poly(methacrylic acid) and poly(ethylene glycol) 
were analyzed which have pH-dependent complexation 
and mucoadhesive properties thought to be potential 
carriers of insulin via an oral route. Nevertheless, further 
optimization of the polymer delivery system is required 
to improve clinical application. Therefore, Morishita et 
al. (2004) studied the effect of ILP particle size (L-ILP: 
180-230 μm, S-ILP: 43-89 μm, SS-ILP: < 43 μm) on 
insulin absorption in the in situ loop system, hypothesizing 
that smaller ILP particle sizes could induce greater 
hypoglycemic effects due to increased mucoadhesive 
capacity. These researchers confirmed burst effect by the 
smaller particles, while demonstrating the delayed release 
of the drug by larger particles which could adhere to the 
mucosa for a more protracted period and release the drug 
in a sustained fashion. 
Déat-Lainé et al. (2013a, 2013b) argued that 
Whey protein and alginate hydrogel microparticles 
are demonstrably supportive of insulin intestinal 
absorption based on their evaluation of the permeability 
enhancement properties observed in Caco-2 cells. The 
same authors reported in another study that the insulin-
loaded Whey protein/alginate microparticles with high 
quantities of entrapped drug exhibited in vitro matrix 
swelling and a protective effect in addition to excellent 
mucoadhesive properties. An improvement in intestinal 
delivery of insulin and increased bioavailability using 
microparticles was recorded.
A study by Hebrard et al. (2013, 2010) confirmed the 
usefulness of whey protein and alginate microparticles 
for successfully delivering probiotics. De et al. (2005) in 
their study of the effect of particle size of nanospheres and 
microspheres on the cellular-association and cytotoxicity 
of paclitaxel in 4T1 Cells, indicated that cell-association 
of paclitaxel increased in 4T1, Caco-2, and Cor-L23/R 
as particle size increased. Paclitaxel delivered by 1-μm 
microspheres was three times more cytotoxic to 4T1 
cells compared to the drug delivered by nanospheres or 
in solution.
In studying the relationship between the effects 
of drugs and the particle size of insulin loaded bio-
adhesive microspheres, Pan et al. (2002) reported all 
the microparticles of three formulated sizes were within 
the desired size range, possessed an increase loading 
capacity, exerted an influence on the release property and 
produced various degrees of hypoglycemic effects after 
10 h. They showed that adhesive Chitosan microparticles 
promoted an increase in the relative pharmacological 
bioavailability of insulin, while the distinct advantage of 
appropriate particle size enhanced the effects of drugs.
The authors prepared fine alginate microparticles (< 
5 µm) by ionotropic gelation-aerosolization technique. 
The screening experiments conducted indicated a 
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relationship between the characteristics of microspheres 
and the amount of polymer sodium alginate and cross 
linker CaCl2 contained in the formula. Previous studies 
had demonstrated that increasing the amount of alginate 
present in the formula produced microparticles possessing 
larger particle size and more efficient drug entrapment 
(Joshi et al. 2012; Rani et al. 2012; Singh et al. 2014). 
In contrast, augmenting the amount of CaCl2 produced 
larger microparticles, but which demonstrated lower 
entrapment efficiency (Balasubramaniam et al. 2007). 
The DoE represents an effective and efficient tool with 
which to investigate the influence of individual formulation 
parameters and their interactions while conducting the 
minimum number of experiments. The application of DoE 
to pharmaceutical formulations has played a key role in 
the identification and optimization of critical formulation 
parameters. 
The present study was undertaken in an attempt 
to understand the factors influencing the preparation 
of alginate microparticles by ionotropic gelation-
aerosolization technique. The effect of different 
concentrations of alginate and  crosslinker, together with 
the combination of these two factors on the physical 
characteristics and the release of metformin from the 




Pharmaceutical grade Metformin HCl was obtained from 
Combiphar, Indonesia, while sodium alginate (Alginic 
acid sodium salt from brown algae medium viscosity, 
MW 216.1212) was purchased from Sigma-Aldrich Inc; 
Both maltodextrin and sodium citrate were acquired from 
Bratachem, Indonesia. All the other chemicals utilised 
were of analytical grade sourced from Merck, Indonesia.
METHODS
MICROPARTICLE FORMULATION
Microparticles were prepared by ionotropic gelation 
aerosolization technique involving different concentrations 
of sodium alginate (1.25 and 1.75%) and concentrations 
of CaCl2 (3 and 5%) as shown in Table 1.
TABLE 1. Formulas containing metformin-loaded alginate microparticles at various 










Na Alginate 1.25 1.25 1.75 1.75
CaCl2 solution 3 5 3 5
PREPARATION OF METFORMIN-LOADED ALGINATE 
MICROPARTICLES
Sodium alginate and CaCl2 was dissolved in 100 mL of 
deionized water at a concentration corresponding to the 
formula in Table 1 and 500 mg of metformin HCl was 
dissolved in 100 mL of alginate solution. The co-solution 
was then introduced into the aerosolization nozzle 
and sprayed into 100 mL of CaCl2 solution which was 
continuously agitated with a magnetic stirrer at a speed of 
1,000 rpm. After 30 min, microspheres were collected by 
means of centrifugation at 2,500 rpm and washed three 
times with distilled water at room temperature, before 
being suspended in 5% of maltodextrin lyoprotectant 
solution and freeze-dried for a period of 29 h.
CHARACTERIZATION OF MICROPARTICLES
PARTICLE SIZE AND MORPHOLOGY
Microparticle size was determined using a 400× 
magnification optical microscope. 300 microparticles 
were measured to calculate their mean diameter, while 
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their shape and surface morphology were subsequently 
examined by means of scanning electron microscopy 
(SEM) at a working distance of 10 mm, with 20.0 kV beam 
energy, and a spot size of 5.0.
FTIR SPECTROSCOPY
FTIR spectroscopy was employed to determine the 
interaction between the drug and polymer within the 
microparticles. KBr pellet samples were taken and scanned 
in an IR range from 600 to 4000 cm–1.
MICROPARTICLE YIELD
The microparticle yield was calculated by subtracting the 
lyoprotectant from the total weight of dry microspheres, 
dividing the resulting figure by the total weight of the 
alginate and adding the weight of the aerosolizating drug 
present in the solution and can be refer from equation (1).
(1)
DRUG LOADING AND ENTRAPMENT EFFICIENCY
150 mg of microspheres were dissolved in 50 mL of 0.5 
M sodium citrate buffer (pH 8.5) and agitated at 1000 rpm 
for seven hours. The metformin content in the sample 
solution was measured using a UV spectrophotometer at 
an absorbance wavelength of 239 nm and calculated by 
comparison with a standard curve produced using a series 
dilution of metformin in sodium citrate. 
Drug loading was calculated on the basis of equation (2):
(2)




Data relating to drug loading, encapsulation efficiency, 
and particle yield and size were analysed by Factorial 
Design to establish the effect of polymer and cross-linker 
content on the characteristics of the metformin loaded 
alginate microspheres. DoE was performed using software 
to determine the pareto chart, interaction plot, contour 
plot, range of polymer and crosslinker content in order to 
produce the optimal microsphere characteristics.
DRUG RELEASE FROM ALGINATE MICROPARTICLES
Drug release studies were carried out by exposing 
metformin-loaded alginate microparticles in sequence to 
release HCl pH 1.2 (2 h) and PBS pH 7.4 (10 h) media. 
3.0 mL of the samples were withdrawn and filtered 
through 0.45 μm millipore filters at predetermined time 
intervals and replaced with the same volume of fresh 
dissolution media. The amount of released metformin was 
determined using a UV spectrophotometer and calculated 
by comparison with a standard curve produced using a 
series dilution of metformin in release media. Drug release 
was expressed as cumulative release (%) calculated by 
dividing the weight of drug released (mg) by the initial 
amount as shown in the equation (4) as follows:
(4)
RESULTS AND DISCUSSION
In order to increase the stability alginate microspheres, 
maltodextrin was used as a lyoprotectant due to its ability 
to maintain the stability of alginate microspheres during 
freeze drying, and prevent aggregation and sedimentation 
(Hariyadi et al. 2015).
METFORMIN HCL IR SPECTRA
IR spectra examination results of metformin HCl-Ca 
alginate microsphere formulas F1, F2, F3 and F4 can be 
seen in Figure 1.
Observations of all four formulas for IR spectra 
showed an interaction between the sodium alginate and 
CaCl2 cross linker solution. This was marked by the 
shifting of the wavenumber and the loss absorption of 
the carboxylate salt group, C-O stretching, and guluronic 
of alginate fingerprints. This showed that alginate was 
crosslinked with CaCl2. Specific groups of metformin 
HCl, namely; N-H stretching, C-H stretching and C-N 
stretching were present in all formulas. This suggests that 
metformin HCl did not participate in the reaction. The 
loss absorption of O-H and C-O stretching of maltodextrin 
indicated an interaction between maltodextrin and the 
microspheres formed due to maltodextrin acting as a 
lyoprotectant through a water replacement hypothesis 
stabilization mechanism.
PARTICLE SIZE OF MICROSPHERES
The measurement results for size were presented in 
a histogram of the ratio between particle size of the 
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From the calculations, the average particle size 
of metformin HCl-Ca alginate microspheres in each 
formula was 1.87 (F1), 2.54 (F2), 2.17 (F3), and 2.84 μm 
(F4), respectively, while that of blank microspheres was 
1.73 (F1), 2.19 (F2), 1.85 (F3), and 2.21 μm (F4). These 
results indicate that the particle size of metformin HCl-Ca 
alginate microspheres in all formulas was larger than that 
of the blank. The observations also showed that particle 
size expanded with increasing concentrations of alginate 
and CaCl2. Increasing concentrations of polymer can 
cause greater viscosity of the media with the result that the 
larger the dimensions of the droplets formed, the greater 
FIGURE 1. IR spectrum of metformin HCl-Ca alginate microsphere formulas and 
Metformin
Note:
F1: Formula 1 using sodium alginate 1.25% and CaCl2 3%, F2: Formula 2 using sodium alginate 1.25% and CaCl2 
5%, F3: Formula 3 using sodium alginate 1.75% and CaCl2 3%, F4: Formula 4 using sodium alginate 1.75% and 
CaCl2 5%, and Metformin: Metformin drug
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the particle size of microspheres produced (Singh et al. 
2014). Moreover, an increase in the concentration of CaCl2 
can cause both higher viscosity of the dispersion media 
and concentration of Ca2 + which can subsequently bind 
with the crosslinker. In addition, the larger guluronic acid 
binds more extensively to the crosslinker to form larger 
microsphere particles (Balasubramaniam et al. 2007).
THE SHAPE AND SURFACE OF THE MICROSPHERES USING 
OPTICAL MICROSCOPE
Observation of the morphology of metformin HCl-Ca 
alginate microspheres by means of an optical microscope 
confirmed that the wet microspheres produced a spherical 
shape and homogeneous particle size.
DRUG LOADING, ENTRAPMENT EFFICIENCY, AND YIELD
Drug loading was measured by firstly producing the 
standard solution of metformin HCl and standard curve. 
The results showed that increasing concentrations of 
alginate and CaCl2 crosslinker reduced the drug loadings of 
metformin HCl probably due to the higher concentration 
of the alginate causing the number of reacting alginate-





































FIGURE 2. Particle size of microspheres formula and blank microspheres
From the measurement results obtained, the standard 
solution of metformin HCl showed aslope (b) of 0.0492, 
intercept (a) of 0.0238 resulting in the regression equation 
of y = 0.0492x + 0.0238 with a correlation coefficient 
(r) of 0.9990. The correlation coefficient obtained was 
greater than the R table (0.878) with a confidence level 
of 95% (5% significance level). This confirmed the 
existence of a linear relationship between metformin HCl 
concentrations through absorbance. The results of drug 
loading, entrapment efficiency, and microsphere yield can 
be seen in Table 2.
TABLE 2. Drug loading, entrapment efficiency, and microsphere yield
Formula
Drug loading (%) Entrapment efficiency (%) Yield (%)
Average 










17.31 ± 0.83 4.77 22.38 ± 1.09 4.88 72.73 ± 4.17 5.73
F2 12.17 ± 0.63 5.18 14.62 ± 1.31 8.99 70.33 ± 3.10 4.41
F3 15.22 ± 0.40 2.65 40.23 ± 1.65 4.10 74.80 ± 5.66 7.56
F4 10.34 ± 0.57 5.54 23.04 ± 1.18 5.11 76.53± 3.90 5.09
amount of dried microspheres to be produced. Therefore, 
the percentage of metformin was lower. Increasing 
concentrations of CaCl2 also reduced the loadings of 
metformin HCl, causing the viscosity of the internal phase 
to affect more profoundly the bond connecting cross linker 
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during the encapsulation process (Balasubramaniam et 
al. 2007; Hariyadi et al. 2015). Statistical analysis by 
factorial design produced a significance of less than 0.05 
which indicated that the difference in the concentrations 
of alginate polymer and CaCl2 resulted in a significant 
difference in the loadings of metformin HCl in the Ca-
alginate microspheres.
With regard to entrapment efficiency, the results 
indicated that increasing concentration of alginate 
polymer can enhance the entrapment efficiency of 
metformin HCl-Ca alginate microspheres, while greater 
concentration of CaCl2 crosslinker can reduce the 
entrapment efficiency of microspheres. Increasing 
concentrations of alginate can improve efficiency due to 
the improved viscosity of alginate causing an increase 
in droplet size. Therefore, a high number of alginate 
molecules were also produced which reacted with 
crosslinkers resulting in larger microsphere particle size 
containing more metformin HCl which was entrapped in 
the microspheres (Balasubramaniam et al. 2007; Nagpal 
et al. 2012). Microsphere entrapment efficiency decreased 
the higher the concentration of CaCl2 crosslinker. Such 
an increase in this concentration can induce greater 
viscosity during the internal phase, in turn, potentially 
affecting the bond which connects the crosslinker during 
the encapsulation process (Hariyadi et al. 2015; Nagpal 
et al. 2012). From the statistical analysis results, the sig. 
value was found to be less than 0.05 which indicated that 
the alginate and CaCl2 concentration showed a significant 
difference in the entrapment efficiency of Ca-alginate 
microspheres. 
The yield results confirmed that increased 
concentrations of alginate polymer can enhance yield 
due to their potentially causing a higher amount of alginate 
to react with Ca2+ crosslinker, thereby resulting in dry 
microspheres. While at low concentrations of alginate 
(1.25%), increased concentrations of CaCl2 reduced yield, 
in contrast, elevated concentrations of alginate (1.75%) 
and increased concentrations of CaCl2 can improve yield. 
At low concentrations (1.25%), alginates that had already 
reacted continued to cross link with Ca2+. Excess Ca2+ 
can affect the bond connecting the cross linker during 
encapsulation, thereby producing fewer microspheres 
(Balasubramaniam et al. 2007; Nagpal et al. 2012). Despite 
the concentration of alginate (1.75%), guluronic acid 
from alginate continuing to crosslink with Ca2+. In this 
case, the concentration of crosslinker was so low as to 
induce the formation of microspheres which were easily 
broken and amorphous (Nethaji et al. 2016; Suksamran 
et al. 2009). The statistical analysis results indicated that 
the differences in concentrations of alginate and CaCl2 
were not significant to the recovery of the Ca-alginate 
microspheres, as indicated by the sig figure of > 0.05.
The low value of metformin HCl loading in the 
microspheres obtained was partly due to metformin 
HCl being a drug possessing low molecular weight and 
high water solubility. Consequently, metformin HCl 
is readily detached from the microspheres during the 
formulation process. The low levels of metformin HCl 
in microspheres are also due to the lack of an optimum 
concentration ratio between the alginate and CaCl2. A 
comparison of alginate concentration and CaCl2 can be 
made and the optimum ratio calculated using an equal 
crosslinker reaction between the carboxylic group of 
alginate with Ca2+ ions of CaCl2. Each molecule of CaCl2 
reacts with two molecules of guluronic acid derived from 
alginate. A simulation of the reaction between guluronic 
acid with Ca2+  ions can be seen in Figure 3.
Based on the calculations performed, the  Ca2+ 
of crosslinking reaction between clusters of alginate 
guluronic with Ca2+, the purity of CaCl2 materials, and the 
ratio of guluronic groups to the type of alginate employed, 
the ratio of the optimum concentration of alginate to 
CaCl2 was one of 1.6:1. Therefore, it is recommended by 
the authors that any subsequent study investigate the use 
of specific concentrations of alginate to CaCl2 in order to 
obtain microspheres with a higher degree of continued 
crosslink resulting in greater drug entrapment.
THE SHAPE AND SURFACE OF THE MICROSPHERES 
OBSERVED WITH A SEM
Based on the drug loading and entrapment efficiency 
results, formulas F1 and F3 were found to be optimal 
and the shape and surface of freeze dry microspheres 
they produced were subsequently observed by means 
of a SEM the results of which can be seen in Figure 4. 
Observation of the morphology of metformin HCl-Ca 
alginate microspheres, the results of which are contained 
in Figure 4, confirmed that the freeze dry microspheres 
of formulas F1 and F3 possessed spherical shapes and 
smooth surfaces.
FIGURE 3. Simulation of a reaction between the alginic acid carboxylic group and Ca2+
2 mole L-Guluronic Acid from 
Na Alginate Ca-Alginate Micropheres
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IN VITRO RELEASE STUDY
Prior to the conduct of the release test, the necessary 
loadings of metformin HCl in microspheres with a Na 
Citrate solution to break the microspheres were determined. 
The metformin HCl content of microspheres obtained 
was subsequently used to calculate the percentage of 
drug initially employed in this study. Release testing was 
conducted in two types of media; firstly, HCl pH 1.2 for 2 
h and, secondly, PBS pH 7.4 for 12 h. 
The results of the release of metformin HCl from the 
microspheres can be seen in Figure 5. The lower release 
of metformin HCl during the first 2 h within the HCl pH 
1.2 medium, compared to the PBS pH 7.4 medium was 
partly due to the acidic pH of H+ ions replacing Ca2+ when 
binding to the carboxylate alginate alginic acid groups to 
form water-insoluble microspheres. In contrast, at alkaline 
pH, Na+ ions present in the PBS component replaced Ca2+ 
to form sodium alginate which was re-dissolved in water.
The rate of release of metformin HCl by alginate 
microspheres is indicated by the value b (slope) of the 
line equation y = bx + a relating to the data release 
profile between the time (x-axis) and %age of cumulative 
metformin HCl released by the microspheres (y axis) 
under consistent conditions. The value release rate obtained 
was then compared with the formula and subjected to 
statistical testing methods by means of a Factorial Design 
ANOVA.
 The release rate was determined by regressed steady 
state points (from 120 to 720 min) in the release profile of 
metformin HCl with time as the x-axis and the cumulative 
percentage of metformin HCl release as the y-axis. 
The regression equation slope represents the speed of 
the metformin HCI microsphers release system. The 
determination results of the release rate of metformin 














FIGURE 4. Observation of formula F1 and F3 Metformin HCl-Ca 
alginate microsphere morphology by means of SEM at 20,000× 
magnification




































PBS pH 7,4HCl pH 1,2
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The results presented here indicate a trend where 
increasing concentrations of alginate lowered the release 
rate of microspheres. Based on Factorial Design ANOVA 
statistical results with a degree of confidence of 95%, it can 
be seen that an increase in the concentration of alginate 
to one of 5% CaCl2 can significantly reduce the release 
rate of metformin HCl (sig = 0.010 <0.050), whereas the 
concentration of 3% CaCl2 did not differ significantly (sig 
0.368 > 0.050). This occurs because the concentration 
of cross linker was low, while the number of Ca2+ ions 
which can bind to the carboxylate groups in alginate 
was also extremely limited (Manjanna et al. 2010). If 
the concentration of alginate alone increased, then the 
amount of Ca2+ available was inadequate to increase the 
degree of cross-linking (Nayak et al. 2013) with the result 
that there was no release of significant barriers.
Increasing concentrations of alginate decreased the 
release rate by lowering the diffusion coefficient of the 
drug substance, thereby causing the number of alginate 
particles coating the surface to increase. They also reduced 
both the pore size particles and the rate of swelling of 
particles within bodily fluids resulting in a deceleration 
in penetration of the particle by body fluids (Suksamran 
et al. 2009).
Observation of the effects of increased cross linker 
concentration confirmed that it accelerated the release 
TABLE 3. Release rate of metformin hcl from ca-alginate microspheres
Formula Average slope ± SD
F1 7.0834×10-2 ± 0.0019541
F2 9.9050×10-2 ± 0.007.3595
F3 6.3229×10-2 ± 0.0045168
F4 7.9730×10-2 ± 0.0060850
rate of metformin HCl microspheres significantly in 
alginate concentrations of 1.25% (sig = 0.001 <0.050) 
and 1.75% (sig = 0.023 <0.050). Similar results were 
obtained during the studies conducted by De et al. (2015) 
and Nayak et al. (2013). This phenomenon was due to, 
firstly, the increased cross linker concentration being too 
high to reach saturation point and, secondly, unbalanced 
binding with polymer. This indicated that increasing 
crosslinker concentration did not enhance the strength of 
the gel because it represented a repulsive force between 
the calcium ions which hindered the release of small 
molecules through the crosslinker networks (Pawar et al. 
2008). Illustrations of the effect of Ca2+ ion concentration 
in crosslinking and the release rate of metformin HCl 
microspheres can be seen in Figure 6.
Based on the statistical results, it can also be seen 
that increasing concentration of alginate did not produce a 
significant difference (sig = 0.096 > 0.050) in relation to the 
release rate of metformin HCl from alginate microspheres. 
That was because the influences of these two factors 
opposed each other in as much as increased concentrations 
of alginate augmented the release rate, whereas increased 
concentrations of crosslink CaCl2 lowered it. No significant 
change in the release rate was found in instances of 






FIGURE 6. Illustration of the effect of Ca2+ ion concentration ( ) the cross linker bond 
( )and release metformin HCl ( ) of microspheres 
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DOE OF MICROSPHERES
The results of the DoE of multiple concentrations of 
alginate and cross linker on entrapment efficiency, drug 
loadings, yield, and particle size are presented in Figure 7.
 Differences in concentrations of alginate (1.25 and 
1.75%) and CaCl2 (3 and 5%) did not produce significant 
results for yield, metformin HCl loading, entrapment 
efficiency, and particle size. However, in terms of yield, 
the effect of alginate concentrations was greater than that 
of CaCl2 concentrations, while the loading of metformin 
HCl, entrapment efficiency, and particle size was more 
influenced by CaCl2 concentration than that of alginate. 
The relationship or interaction between concentrations of 
alginate and crosslinker on yield, entrapment efficiency, 
drug content, and particle size can be seen in Figure 8.
 The CaCl2 contour plot of the results in Figure 
9 showed that increased concentrations of alginate 
microspheres can improve yield. CaCl2 can reduce 
microsphere yield, although an increase in yield due to the 
concentration of alginate was more influential than the 
decline in yield due to that of CaCl2. Yield above 76% can 
be obtained from alginate at concentrations of more than 
1.6% and a concentration of CaCl2 about 4.5 - 5%. The 
efficiency of entrapment can also be enhanced by increased 
concentrations of alginate, but the intensified concentration 
CaCl2 can reduce entrapment efficiency (EE). EE in excess 
of 40% can be obtained from alginate concentrations of 
more than 1.6% and concentration of CaCl2 3-3.5%.
The high loading of metformin HCl can be obtained 
with lower concentrations of alginate (<1.3%) and CaCl2 
(3-3.5%). The loading of metformin HCl concentration 
decreased with increasing concentrations of alginate and 
CaCl2. In terms of size, the smaller particle size of less 
than 2 µm can be obtained from lower concentrations 
of alginate and CaCl2. However, although increasing 
concentrations of alginate above 1.75% and CaCl2 
above 5% increased the size of particles, the resulting 
microspheres remained within the desired range for oral 
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FIGURE 7. The pareto chart of multiple concentrations of alginate and 
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FIGURE 8. Interaction between concentrations of alginate and CaCl2 
on yield, entrapment efficiency, drug loading and particle size





























Contour Plot of Drug Loading CaCl2 vs Alginate


























Contour Plot of Entrapment Efficiency CaCl2 vs Alginate



























Contour Plot of Yield CaCl2 vs Alginate





























Metformin HCl-Ca alginate microspheres were 
successfully produced using an aerosolisation technique. 
This research studied the design of experiments on 
the concentration of alginate and CaCl2 crosslinker 
within the physical characteristics of metformin HCl-Ca 
alginate microspheres. The results of several evaluations 
indicated that intensifying the concentrations of alginate 
microspheres increased the particle size, reduced the 
loading of metformin HCl, and improved the entrapment 
efficiency of microspheres. Moreover, intensifying 
the concentration of CaCl2 crosslinkers increased 
microsphere particle size, while reducing the loading of 
metformin HCl and entrapment efficiency of microspheres. 
The difference in concentrations of alginate within a CaCl2 
crosslinker produced no effect on the shape and appearance 
of the microspheres, or their yield.
Metformin alginate microspheres prepared by 
ionotropic gelation method and aerosolization techniques 
can maintain the release of metformin HCl for more than 
12 h. Metformin HCl released from alginate microspheres 
was affected by differences in the concentrations of 
polymer and crosslinker. Increased concentrations 
of alginate (from 1.25 to 1.75%) reduced the release 
of metformin HCl in microspheres, while increased 
concentrations of CaCl2 (from 3 to 5%) enhanced in 
the release of metformin HCl alginate microspheres. It 
was also shown that simultaneously intensifying the 
concentration of alginate and CaCl2 did not affect the 
metformin HCl released by alginate microspheres. DoE 
made several recommendations for further formulation 
of microspheres.
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